16
Jun
2027
National Exhibition and Convention Center
16 Jun 2027 - 18 Jun 2027
stand 52A32d

Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.

About Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.

Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. is a global innovation-driven pharmaceutical company in China, and is a core member enterprise of Fosun Pharma. Business covers the whole healthcare industry chain including pharmaceutical R&D, manufacturing, wholesale and distribution. Several production lines have passed FDA /EU site audits.  Key products include Human Insulins and GLP-1 products, EPO, and Heparin Sodium, OSD products such as Ticagrelor Tabs, Tofacitinib Tabs, Crizotinib Caps and Osimertinib Tabs.  Key APIs includes Insulins, Heparin Sodium, Venetoclax and Febuxostat

Certifications

Meet us at

  • CPHI & PMEC China 2027

    National Exhibition and Convention Center
    16 Jun 2027 - 18 Jun 2027
    stand 52A32d
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Contact info

Products from Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd. (21)